The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Recent advances of β-catenin small molecule inhibitors for cancer therapy: Current development and future perspectives.EBI
Sichuan University
An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds.EBI
Universita Degli Studi Di Palermo
Furazans in Medicinal Chemistry.EBI
Treventis
Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer.EBI
Ocean University of China
Peptidomimetics: An Overview of Recent Medicinal Chemistry Efforts toward the Discovery of Novel Small Molecule Inhibitors.EBI
Ri.Med Foundation
Cyclic Peptide Screening Methods for Preclinical Drug Discovery.EBI
University of Washington
Targeting the interaction of β-catenin and TCF/LEF transcription factors to inhibit oncogenic Wnt signaling.EBI
Vu University Amsterdam
Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale.EBI
University of Southampton
Target β-catenin/CD44/Nanog axis in colon cancer cells by certain N'-(2-oxoindolin-3-ylidene)-2-(benzyloxy)benzohydrazides.EBI
King Saud University
2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's diseaseBDB
Merck Sharp & Dohme